nach oben

Erschienen in:

01.05.2015 | Original Communication

Validation of the multimodal assessment of capacities in severe dementia: a novel cognitive and functional scale for use in severe dementia

verfasst von: Sloane Heller, Carolina Mendoza Rebolledo, Carmen Rodríguez Blázquez, Laura Carrasco Chillón, Almudena Pérez Muñoz, Irene Rodríguez Pérez, Pablo Martínez-Martín

Erschienen in: Journal of Neurology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

The multimodal assessment of capacities in severe dementia (MAC-SD), a novel cognitive and functional assessment, was developed for use with patients with severe dementia. Its psychometric attributes were examined in a unicenter, open, observational study. The MAC-SD along with the Spanish language Severe Mini Mental Exam were administered to 103 patients with a diagnosis of severe dementia. Psychometric analyses were performed to determine acceptability, reliability, validity, and responsiveness. As a whole, the MAC-SD sections showed no floor effects, satisfactory internal consistency, reproducibility, construct validity, precision, and sensitivity to change. The MAC-SD performed as a useful, valid, and potentially responsive tool to measure cognition and functioning in the most advanced stages of dementia.

Nur mit Berechtigung zugänglich

Reisberg B (2007) Global measures: utility in defining and measuring treatment response in dementia. Int Psychogeriatr 19:421–456CrossRefPubMed

Bonnel WB (1996) Not gone and not forgotten: a spouse’s experience of late-stage Alzheimer’s disease. J Psychosoc Nurs Ment Health Serv 34:23–27PubMed

Schmitt FA (1997) SIB: current validity and assessment of longitudinal change in AD. Alzheimer Dis Assoc Dis 11:S51–S56CrossRef

Voisin T, Reynish E, Portet F, Feldman H, Vellas B (2004) What are the treatment options for patients with severe AD? CNS Drugs 18:575–583CrossRefPubMed

Robert P, Ferris S, Gauthier S, Ihl R, Winblad B, Tennigkeit F (2010) Review of AD Scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimers Res Ther 22:24CrossRef

Schmitt FA, Cragar D, Ashford JW, Reisberg B, Ferris S, Möbius HJ, Stöffler A (2002) Measuring cognition in advanced AD for clinical trials. J Neural Transm Suppl 62:135–148CrossRefPubMed

Holthoff VA, Ferris S, Ihl R, Robert P, Winblad B, Gauthier S, Sternberg K, Tennigkeit F (2011) Validation of the relevant outcomes scale for Alzheimer’s disease: a novel multidomain assessment for daily medical practice. Alzheimers Res Ther 3:27PubMedCentralCrossRefPubMed

Olazarán J, Agüera-Ortiz L, Osorio RS, León-Salas B, Dobato JL, Cruz-Orduña I, González B, Valentí M, Gil-Ruiz N, Frades B, Ramos García MI, Martínez-Martín P (2012) Promoting clinical research in advanced dementia: early clinical results of the Alzheimer Center Reina Sofia Foundation. J Alzheimers Dis 28:211–222PubMed

Martínez-Martín P, Avila J, AD Research Unit Investigators (2010) Alzheimer Center Reina Sofia Foundation: fighting the disease and providing overall solutions. J Alzheimers Dis 21:337–348PubMed

10.

Auer S, Reisberg B (1997) The GDS/FAST staging system. Int Psychogeriatr 9:167–171CrossRefPubMed

11.

Buiza C, Navarro A, Díaz-Orueta U, González MF, Alaba J, Arriola E, Hernández C, Zulaica A, Yanguas JJ (2011) Short evaluation of cognitive state in advanced stages of dementia: preliminary results of the Spanish validation of the Severe-Mini Mental State Examination. Rev Esp Geriatr Geruntol 46:131–138CrossRef

12.

Mokkik L, Terwee C, Knol D, Stratford P, Alonso J, Patrick D, Bouter L, de Vet H (2010) The COSMIN checklist for evaluating the methodological quality of studies on measurement of properties: a clarification of its content. BMC Med Res Methodol 10:22CrossRef

13.

Martinez-Martin P, Frades-Payo B, Agüera-Ortiz L, Ayuga-Martinez A (2012) A short scale for evaluation of neuropsychiatric disorders in Parkinson’s disease: first psychometric approach. J Neuro 259:2299–2308CrossRef

14.

Martinez Martin P, Forjaz MJ (2012) How to evaluate validation data. In: Sampaio C, Goetz CG, Schrag A (eds) Rating scales in Parkinson’s disease. Oxford University Press, Oxford, pp 16–41CrossRef

15.

Ware JE, Gandek B (1998) Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International quality of life assessment. J Clin Epidemiol 51:945–952CrossRefPubMed

16.

Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martínez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2013) Expanded and independent validation of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). J Neurol 260:228–236CrossRefPubMed

17.

Juniper EF, Guyatt GH, Jaeschke R (1996) How to develop and validate a new health-related quality of life instrument. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 49–56

18.

Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakesh R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR (2009) International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease. Neurology 73:1584–1591CrossRefPubMed

19.

Middel B, van Sonderen E (2002) Statistical significant change vs. relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating the magnitude of intervention-related change in health services research. Int J Integr Care 2:e15PubMedCentralPubMed

20.

Cohen J (1977) Statistical power analysis for the behavioral sciences, Rev edn. Academic Press, New York

21.

Deyo RA, Centor RM (1986) Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis 39:897–906CrossRefPubMed

22.

Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42CrossRefPubMed

23.

McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM (1984, 2013) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–44

24.

Benke T, Andree B, Hittmair M, Gerstenbrand F (1990) Speech changes in dementia. Fortschr Neurol Psychiatr 58:215–223CrossRefPubMed

25.

Vink AC, Bruinsma MS, Scholten RJPM (2007) Music therapy for people with dementia (Review). Cochrane Reviews. http://www.bibliotecacochrane.com/pdf/CD003477.pdf. Accessed 15 Sept 2013

26.

Hall L, Orrell M, Stott J, Spector A (2012) Cognitive stimulation therapy (CST): neuropsychological mechanisms of change. Int Psychogeriatr 25:479–489CrossRefPubMed

27.

Reisberg B, Ferris SH, de Leon MJ, Crook T (1988) Global Deterioration Scale (GDS). Psychopharmacol Bull 24:661–663PubMed

28.

Schmidt R, Kienbacher E, Benke T, Dal-Bianco P, Delazer M, Ladurner G, Jellinger K, Ransmayer G, Schmidt H, Stögmann E, Friedrich J, Wehringer C (2008) Sex differences in Alzheimer’s disease. Neuropsychiatry 22:1–15

29.

Xing Y, Wei C, Chu C, Zhou A, Li P, Wu L, Song H, Zuo X, Wang F, Qin W, Li D, Tang Y, Jia XF, Jia J (2012) Stage-specific gender differences in cognitive and neuropsychiatric manifestations of vascular dementia. Am J Alzheimers Dis Other Demen 27:433–438CrossRefPubMed

30.

Bernick C, Cummings J, Raman R, Sun X, Aisen P (2012) Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials. Arch Neurol 69:901–905CrossRefPubMed

31.

Beckerman H, Roebroeck ME, Lankhorst GJ, Becher JG, Bezemer PD, Verbeek AL (2001) Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res 10:571–578CrossRefPubMed

32.

Maheswaran H, Weich S, Powell J, Stewart-Brown S (2012) Evaluating the responsiveness of the Warwick Edinburgh Mental Well-Being Scale (WEMWBS): group and individual level analysis. Health Qual Life Outcomes 10:156PubMedCentralCrossRefPubMed

33.

Rapp MA, Schnaider-Beeri M, Schmeidler J, Sano M, Silverman JM, Haroutunian V (2005) Relationship of neuropsychological performance to functional status in nursing home residents and community-dwelling older adults. Am J Geriatr Psychiatry 13:450–459CrossRefPubMed

34.

Sikkes SAM, de Lange-de Klerk ESM, Pijnenburg YAL, Scheltens P, Uitdehaag BMJ (2009) A systematic review of instrumental activities of daily living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatr 80:7–12CrossRefPubMed

35.

Ford GR, Haley WE, Thrower SL, West CA, Harrell LE (1996) Utility of Mini-Mental State Exam scores in predicting functional impairment among White and African American dementia patients. J Gerontol A Biol Sci Med Sci 51:M185–M188CrossRefPubMed

36.

Lehfield H, Erzigkeit H (2000) Loss of activities of daily living function (ADL) and cognitive impairment in various stages of dementia. A comparison of ADL informant ratings, ADL self ratings and psychometric test results. Fortschr Neurol Psychiatr 68:262–269CrossRef

37.

Juva K, Makela M, Erkinjuntti T, Sulkava R, Yukosi R, Valvanne J, Tilvis R (1997) Functional assessment scales in detecting dementia. Age Ageing 26:393–400CrossRefPubMed

38.

Galik E (2010) Function-focused care for LTC residents with moderate-to-severe dementia: a social ecological approach. Ann Longterm Care 18:27–32

Titel: Validation of the multimodal assessment of capacities in severe dementia: a novel cognitive and functional scale for use in severe dementia
verfasst von: Sloane Heller
Carolina Mendoza Rebolledo
Carmen Rodríguez Blázquez
Laura Carrasco Chillón
Almudena Pérez Muñoz
Irene Rodríguez Pérez
Pablo Martínez-Martín
Publikationsdatum: 01.05.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 5/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-015-7692-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2015

Neuroanatomical correlates of severe cardiac arrhythmias in acute ischemic stroke

Ocular motor measures of cognitive dysfunction in multiple sclerosis I: inhibitory control

Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold?

TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations

Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study

Diagnosis of muscle diseases presenting with early respiratory failure